Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher H, Bernasconi E, Perrin LH, Yerly S, Hirschel B.

Antivir Ther. 1998;3 Suppl 4:65-7.

PMID:
10723515
2.

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B.

AIDS. 1998 May 28;12(8):F71-7.

PMID:
9631134
3.

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH.

J Infect Dis. 1998 Mar;177(3):783-5.

PMID:
9498464
4.

Controversies: does the CD4+ cell count reflect clinical efficacy?

Kinloch-de-Loës S, Perrin LH, Hirschel BJ, Perneger TV.

JAMA. 1996 Oct 16;276(15):1219; author reply 1919-20. No abstract available.

PMID:
8849744
5.

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64.

PMID:
7882100
6.

Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load.

Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, Suter S, Perrin LH, Siegrist CA.

AIDS. 1994 Oct;8(10):1503-4. No abstract available.

PMID:
7818826
7.

Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases.

Kinloch-de Loës S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH.

Clin Infect Dis. 1993 Jul;17(1):59-65.

PMID:
8353247
8.

Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor.

de Saussure P, Yerly S, Tullen E, Perrin LH.

Transfusion. 1993 Feb;33(2):164-7.

PMID:
8430457
9.

Identification and purification of glucose phosphate isomerase of Plasmodium falciparum.

Srivastava IK, Schmidt M, Grall M, Certa U, Garcia AM, Perrin LH.

Mol Biochem Parasitol. 1992 Sep;54(2):153-64.

PMID:
1435856
10.

Plasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasite.

Grall M, Srivastava IK, Schmidt M, Garcia AM, Mauël J, Perrin LH.

Exp Parasitol. 1992 Aug;75(1):10-8.

PMID:
1639156
11.

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH.

J Infect Dis. 1992 Aug;166(2):269-76.

PMID:
1353103
12.

Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.

Chamot E, de Saussure P, Hirschel B, Déglon JJ, Perrin LH.

AIDS. 1992 Apr;6(4):430-1. No abstract available.

PMID:
1616640
13.

Frequencies of HIV-reactive B cells in seropositive and seronegative individuals.

Zubler RH, Perrin LH, Doucet A, Zhang X, Huang YP, Miescher PA.

Clin Exp Immunol. 1992 Jan;87(1):31-6.

14.

Measurement of serum haptoglobin as an indicator of the efficacy of malaria intervention trials.

Sisay F, Byass P, Snow RW, Greenwood BM, Perrin LH, Yerly S.

Trans R Soc Trop Med Hyg. 1992 Jan-Feb;86(1):14-6.

PMID:
1566291
15.
16.

Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria.

Srivastava IK, Schmidt M, Grall M, Yerly S, Garcia AM, Bouvier M, Takacs B, Dobeli H, Perrin LH.

J Trop Med Hyg. 1991 Jun;94(3):189-94.

PMID:
2051524
17.

Structural diversity of Plasmodium falciparum gp200 is detected by T cells.

Simitsek PD, Ramirez E, Perrin LH.

Eur J Immunol. 1990 Aug;20(8):1755-9.

PMID:
2209687
18.

Human immunodeficiency virus DNA amplification and serology in blood donors.

Perrin LH, Yerly S, Adami N, Bachmann P, Bütler-Brunner E, Burckhardt J, Kawashima E.

Blood. 1990 Aug 1;76(3):641-5.

PMID:
2198964
19.

Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase.

Döbeli H, Trzeciak A, Gillessen D, Matile H, Srivastava IK, Perrin LH, Jakob PE, Certa U.

Mol Biochem Parasitol. 1990 Jun;41(2):259-68.

PMID:
2204832
20.

Initiation of translation at a UAG stop codon in the aldolase gene of Plasmodium falciparum.

Ghersa P, Shrivastava IK, Perrin LH, Döbeli H, Becherer DJ, Matile H, Meier B, Certa U.

EMBO J. 1990 May;9(5):1645-9.

21.

Development of a haptoglobin ELISA. Its use as an indicator for malaria.

Yerly S, Bouvier M, Rougemont A, Srivastava I, Perrin LH.

Acta Trop. 1990 May;47(4):237-44.

PMID:
1973025
22.

Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase.

Srivastava IK, Schmidt M, Certa U, Döbeli H, Perrin LH.

J Immunol. 1990 Feb 15;144(4):1497-503.

PMID:
2406342
23.

Autologous transfusion practice.

Burckhardt JJ, Bütler-Brunner E, Perrin LH, Bachmann P.

Vox Sang. 1990;58(3):242-5. No abstract available.

PMID:
2339536
24.

Recombinant polypeptides for serology of malaria.

Srivastava IK, Takacs B, Caspers P, Certa U, McGregor IA, Scaife J, Perrin LH.

Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):317-21.

PMID:
2694465
25.

Asexual blood stage vaccines: from merozoites to peptides.

Perrin LH, Simitsek P, Fasani-Ghersa P.

Trans R Soc Trop Med Hyg. 1989;83 Suppl:53-6. Review.

PMID:
2696161
26.

Variation in p126, a parasitophorous vacuole antigen of Plasmodium falciparum.

Coppel RL, Crewther PE, Culvenor JG, Perrin LH, Brown GV, Kemp DJ, Anders RF.

Mol Biol Med. 1988 Dec;5(3):155-66.

PMID:
3072468
27.

[Reversal of positive serology for human immunodeficiency virus (HIV). Apropos of 2 case reports].

Perrin LH, Zubler R, Hirschel B, Martin JL, Salomon D, Saurat JH, Fryc O.

Schweiz Med Wochenschr. 1988 Nov 12;118(45):1641-4. French.

PMID:
3187480
28.

Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.

Huang YP, Perrin LH, Miescher PA, Zubler RH.

J Immunol. 1988 Aug 1;141(3):827-33.

PMID:
3135313
29.

Development of malaria vaccines.

Perrin LH, Simitsek P, Srivastava I.

Trop Geogr Med. 1988 Jul;40(3):S6-21. Review. No abstract available.

PMID:
3055567
30.

Aldolase activity of a Plasmodium falciparum protein with protective properties.

Certa U, Ghersa P, Döbeli H, Matile H, Kocher HP, Shrivastava IK, Shaw AR, Perrin LH.

Science. 1988 May 20;240(4855):1036-8.

PMID:
3285469
31.

Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies.

Wen L, Hanvanich M, Werner-Favre C, Brouwers N, Perrin LH, Zubler RH.

Eur J Immunol. 1987 Jun;17(6):887-92.

PMID:
3297736
32.

Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

Cheung A, Leban J, Shaw AR, Merkli B, Stocker J, Chizzolini C, Sander C, Perrin LH.

Proc Natl Acad Sci U S A. 1986 Nov;83(21):8328-32.

33.

[Immunology and molecular biology: targetting of a vaccine].

Perrin LH, Mach B.

Ther Umsch. 1986 Feb;43(2):148-54. Review. French. No abstract available.

PMID:
3515610
34.

Defined Plasmodium falciparum antigens in malaria serology.

Gabra MS, Grossiord D, Perrin LH, Shaw A, Cheung A, McGregor IA.

Bull World Health Organ. 1986;64(6):889-96.

35.

Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys.

Perrin LH, Merkli B, Gabra MS, Stocker JW, Chizzolini C, Richle R.

J Clin Invest. 1985 May;75(5):1718-21.

36.

Prekallikrein activation in the adult respiratory distress syndrome.

Schapira M, Gardaz JP, Py P, Lew PD, Perrin LH, Suter PM.

Bull Eur Physiopathol Respir. 1985 May-Jun;21(3):237-41.

PMID:
3873975
37.

Complement activation in the adult respiratory distress syndrome following cardiopulmonary bypass.

Lew PD, Forster A, Perrin LH, Suter S, Neidhart P, Waldvogel F, Suter PM.

Bull Eur Physiopathol Respir. 1985 May-Jun;21(3):231-5.

PMID:
3873974
38.
39.

Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.

Perrin LH, Merkli B, Loche M, Chizzolini C, Smart J, Richle R.

J Exp Med. 1984 Aug 1;160(2):441-51.

40.

Immunization against Plasmodium falciparum asexual blood stages using soluble antigens.

Perrin LH, Loche M, Dedet JP, Roussilhon C, Fandeur T.

Clin Exp Immunol. 1984 Apr;56(1):67-72.

41.

[Preliminary study on monoclonal antibodies against Schistosoma japonicum].

Yan ZZ, Perrin LH, Ramirez E, Lambert PH.

Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1984;2(3):154-7. Chinese. No abstract available.

PMID:
6391725
43.

Antigenic characterization of plasmodia.

Perrin LH, Rodriguez da Silva L, Dayal R.

Contemp Top Immunobiol. 1984;12:109-25. Review. No abstract available.

PMID:
6365439
45.

Partial myeloperoxidase deficiency in preleukemia.

Cech P, Markert M, Perrin LH.

Blut. 1983 Jul;47(1):21-30.

PMID:
6305446
46.

High levels of complement breakdown products in tuberculous pleural effusions.

Lew DP, Perrin LH, Vassalli JD, Suter S, Lambert PH, Waldvogel FA.

Clin Exp Immunol. 1983 Jun;52(3):569-74.

47.

Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes.

Celada A, Cruchaud A, Perrin LH.

J Parasitol. 1983 Feb;69(1):49-53.

PMID:
6338199
48.

Plasmodium falciparum polypeptides released during in vitro cultivation.

Rodriguez da Silva L, Loche M, Dayal R, Perrin LH.

Bull World Health Organ. 1983;61(1):105-12.

49.

The hematology of malaria in man.

Perrin LH, Mackey LJ, Miescher PA.

Semin Hematol. 1982 Apr;19(2):70-82. Review. No abstract available.

PMID:
7041265
50.

Supplemental Content

Loading ...
Support Center